Research and
education
deserve attention.

Which is just
what we create.

Client's-News

18. July 2018

Biotech Company Marinomed Successfully Tests New Combination Drug Against Viral Respiratory Tract Infection:

Carragelose®, a broadly effective compound for treating cold viruses, can be combined with Xylometazoline, a compound that reduces inflammation in the nasal mucosa without sacrificing efficacy. This is reflected in the findings of an in vitro study which will form the basis for developing a single drug that combats viral infections as well as freeing up blocked airways. The study was carried out by Vienna-based biotech company Marinomed Biotech AG (Marinomed) and the results have now been published in an international journal.

read more

 
Latest news from Facebook Facebook

PR MIT LEBERBLUT

Meist geben wir in unserer Arbeit Herzblut für unsere Kunden – doch das Ludwig Boltzmann Institut für experimentelle und klinische Traumatologie forderte mehr:

Leberblut wurde als Demonstration für Journalisten gebraucht.

Die hat es gefreut - und a bissl gegraust.
... See MoreSee Less

PR MIT LEBERBLUT

Meist geben wir in unserer Arbeit Herzblut für unsere Kunden – doch das Ludwig Boltzmann Institut für experimentelle und klinische Traumatologie forderte mehr:

Leberblut wurde als Demonstration für Journalisten gebraucht.

Die hat es gefreut - und a bissl gegraust.

09.05.18

PR&D - Public Relations für Forschung & Bildung

News mal anders - Video statt ArtikelOptimised hearing devices featuring fibre-optic technology. Groundbreaking technology for the transmission of acoustic signals, designed for use in fully imp... ... See MoreSee Less

Video image

Comment on Facebook

Upcoming Events

AM PULS Nr. 61

Blue Gold –

Water as a scarce resource with conflict potential

 

(in German only)

 

ap-schriftzug

Wednesday, 26. September 2018 • 6 pm

Kunden-News

18. July 2018

Biotech Company Marinomed Successfully Tests New Combination Drug Against Viral Respiratory Tract Infection:

Carragelose®, a broadly effective compound for treating cold viruses, can be combined with Xylometazoline, a compound that reduces inflammation in the nasal mucosa without sacrificing efficacy. This is reflected in the findings of an in vitro study which will form the basis for developing a single drug that combats viral infections as well as freeing up blocked airways. The study was carried out by Vienna-based biotech company Marinomed Biotech AG (Marinomed) and the results have now been published in an international journal.

News lesen

Kunden-News

23. May 2018

Long-term Psychological Study Confirms: Time is The Best Medicine Against Homesickness:

Time heals homesickness – and quickly, according to a unique long-term study on international students. A propensity towards neuroticism and the desire to keep others happy are among the factors associated with the development of homesickness. However, the study also found that the level of homesickness among those currently studying abroad is generally low.

News lesen

Kunden-News

11. April 2018

Computing Power to Optimise the Mobile Emergency Care Network:

Optimised distribution of emergency medical service stations can ensure rapid emergency care for even greater swathes of the population – and save money at the same time. This is the result of a study by Karl Landsteiner University of Health Sciences in Krems (KL Krems), Austria, published recently in an international journal.

News lesen